Study identifies non-statin cholesterol drugs with potential to lower liver cancer risk

FHS
July 29, 2024
2:09 pm

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals’ risk of developing liver cancer.

Helicopters rescued patients in ‘apocalyptic’ flood. Other hospitals are at risk, too.

April Boyd texted her husband before she boarded the helicopter. “So, I don’t want to be dramatic,” she wrote on Sept. 27, “but we are

December 16, 2024

Prior Authorization and Interoperability – Changing the Dynamics of Medicare

Don Rucker, MD – Chief Strategy Officer, 1upHealth CMS and Medicare are trying to change the dynamics of American healthcare. No need to rehash the

February 22, 2024

Epigenetic changes can contribute to the development of type 2 diabetes

Do epigenetic changes cause type 2 diabetes, or do the changes occur only after a person has become ill? A new study by researchers at

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.